Journals / Türk Kardiyoloji Derneği Arşivi / 2006 / Cilt: 34 - Sayı: 4

Congenital heart disease and pregnancy

Doğumsal kalp hastalığı ve gebelik

Pages
255–264
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Women with high or intermediate risks should be referred for specialty care.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thanks to continuing progress in pediatric cardiac surgery and medical care, most women with congenital heart disease (CHD) reach childbearing age and consider pregnancy.
📊
Key Findings & Data:Significant hemodynamic changes occur during normal pregnancy.
💡
Conclusion & Impact:Women with high or intermediate risks should be referred for specialty care.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Thanks to continuing progress in pediatric cardiac surgery and medical care, most women with congenital heart disease (CHD) reach childbearing age and consider pregnancy. Significant hemodynamic changes occur during normal pregnancy. Cardiac output increases by 50% while peripheral vascular resistance and blood pressure decrease. In the presence of maternal CHD, these hemodynamic changes can cause deterioration in cardiac functions, exacerbation of cardiac symptoms, and may result in maternal death and fetal loss. In spite of these complications, pregnancy is well tolerated in minimally symptomatic women with good ventricular function and normal oxygen saturation except in those with Eisenmenger syndrome, left heart obstruction, and Marfan syndrome. A planned pregnancy is preferable in women with CHD. Before pregnancy, maternal and fetal risks should be assessed, advisability of pregnancy must be determined, and if possible, cardiac abnormalities must be corrected or palliated. A careful and close follow-up is necessary during pregnancy. Women with high or intermediate risks should be referred for specialty care.

Özet

Doğumsal kalp hastalığı olan kadınların çoğu, sürekli gelişim gösteren pediyatrik kardiyak cerrahi ve tıbbi tedavi yöntemleri sayesinde erişkin yaşa ulaşmakta ve çocuk sahibi olmayı istemektedir. Normal gebelik sırasında önemli hemodinamik değişiklikler oluşur. Periferik vasküler direnç ve kan basıncı düşerken, kardiyak debi %50 artar. Annede doğumsal kalp hastalığı olduğunda bu hemodinamik değişiklikler kardiyak fonksiyonların bozulmasına, semptomların alevlenmesine ve hatta anne ve fetusun kaybına neden olabilir. Bu komplikasyonlara karşın, Eisenmenger sendromu, sol kalp obstrüksiyonu, Marfan sendromu gibi hastalıklar dışında, ventrikül fonksiyonları iyi, semptomları hafif, oksijen satürasyonu normal olan kadınlarda gebelik iyi tolere edilir. Doğumsal kalp hastalığı bulunan bir kadında planlanmış gebelik tercih edilir. Gebelik öncesinde anne ve fetusla ilgili risk tayini yapılmalı, gebeliğin uygun olup olmadığı belirlenmeli ve eğer mümkünse kardiyak sorunlar gebelik öncesi dönemde düzeltilmeli veya hafifletilmelidir. Gebelik oluştuğunda hastaların yakın takibi gerekir; orta ve yüksek riskli hastaların takibi tam teşekküllü hastanelerde uzman ekip tarafından yapılmalıdır.

🔖

Cite This Article

YÜKSEL, H. (2022). Congenital heart disease and pregnancy. Türk Kardiyoloji Derneği Arşivi, Cilt: 34 - Sayı: 4, 255–264. https://ajindex.com/articles/633702

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Perloff JK. Congenital heart disease in adults. A new cardiovascular subspecialty. Circulation 1991;84: 1881-90
  2. Türk Kardiyoloji Derneği, Türkiye Kalp Raporu 2000. Türk halkında kalp hastalıkları prevelansı ve trendleri: Doğuştan kalp hastalığı. İstanbul: Yenilik Basımevi; 2000
  3. Pitkin RM, Perloff JK, Koos BJ, Beall MH. Pregnancy and congenital heart disease. Ann Intern Med 1990; 112:445-54
  4. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992;68:540-3
  5. Siu S, Colman JM. Cardiovascular problems and pregnancy: an approach to management. Cleve Clin J Med 2004;71:977-85
  6. Whittemore R, Hobbins JC, Engle MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982; 50:641-51
  7. Shime J, Mocarski EJ, Hastings D, Webb GD, McLaughlin PR. Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol 1987;156:313-22
  8. Romano-Zelekha O, Hirsh R, Blieden L, Green M, Shohat T. The risk for congenital heart defects in offspring of individuals with congenital heart defects. Clin Genet 2001;59:325-9
  9. Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996. Am J Obstet Gynecol 1998;179(6 Pt 1):1643-53
  10. Connolly HM. Pregnancy in women with congenital heart disease. Curr Cardiol Rep 2005;7:305-9
  11. Head CE, Thorne SA. Congenital heart disease in pregnancy. Postgrad Med J 2005;81:292-8
  12. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21
  13. Colman JM, Sermer M, Seaward PG, Siu SC. Congenital heart disease in pregnancy. Cardiol Rev 2000;8:166-73
  14. Zuber M, Gautschi N, Oechslin E, Widmer V, Kiowski W, Jenni R. Outcome of pregnancy in women with congenital shunt lesions. Heart 1999;81:271-5
  15. Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol 1994;23:1194-8
  16. Bonow RO, Carabello B, de Leon AC, Edmunds LH Jr, Fedderly BJ, Freed MD, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 1998;7:672-707
  17. Lao TT, Sermer M, Ma